Are you interested in helping create tools for patients to better manage their chronic kidney conditions? You may be able to participate in an online survey to provide information on how you as a patient or caregiver handle living with FSGS or IgA. Compensation provided.

The CureGN Network acts as a "library" of data for investigators across the world to use to help us ask the following questions: 1) What is the disease?; 2) Why did it happen to me?; 3) Can it be passed down to my family members?; 4) What treatments work the best with the least side effects?

Help other teens with type 1 diabetes by joining the MyPlan project! We want to learn whether following an eating plan designed for the unique preferences and lifestyles of teens with type 1 diabetes can improve blood sugar management. Ongoing support from a dietician and compensation provided.

We would like to get a blood sample before your COVID vaccine and then a various time points after you get your COVID vaccine. We are trying to learn more about how patients with autoimmune disease produce antibodies after they are vaccinated, especially those being treated with immunosuppressive drugs.

The study tests the safety and efficacy of a new type of drug, administered by intravenous infusion, for the treatment of lupus nephritis or IgA Nephropathy. You might be on the drug or on the placebo (no active drug ) and will help to figure out if this new drug is a good alternative or complement to existing drugs.

We are looking for healthy volunteers to donate a one time blood sample to help us with our research. Your sample will be compared to subjects with end stage kidney disease on dialysis.

The CureGN Network acts as a "library" of data for investigators across the world to use to help us ask the following questions: 1) What is the disease?; 2) Why did it happen to me?; 3) Can it be passed down to my family members?; 4) What treatments work the best with the least side effects?

Current routine tests for patients with autoimmune diseases don';t always detect disease in all patients and poorly reflect how patient symptoms and treatment responses can vary. The development of tests to fine new autoimmune markers will help better personalize treatments strategies and may give doctors indicators to better track disease progression and therapy response. If you participate, we will ask for a one time donation of blood. Compensation provided.

If you have been treated with ANCA vasculitis and you are now in remission, you may be able to participate in a study to test if a specific blood test can help your doctor decide if you need maintenance therapy.

Have you been diagnosed with IgA Nephropathy and are you considering trying a new, experimental drug for treatment? Researchers want to learn more about the safety and effectiveness of VIS649 to treat IgAN.